La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Avadel Pharmaceuticals Gestione
Gestione criteri di controllo 3/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Greg Divis
Amministratore delegato
US$985.2k
Compenso totale
| Percentuale dello stipendio del CEO | 60.9% |
| Mandato del CEO | 5.6yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 4.7yrs |
| Durata media del Consiglio di amministrazione | 6.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Avadel Pharmaceuticals: Inflection Point Ahead
Jun 16Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution
Apr 02Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation Overhang
Mar 05Avadel Pharmaceuticals: Strong Launch Of Lumryz With A Legal Risk Backdrop
Jan 28Is Avadel Pharmaceuticals (NASDAQ:AVDL) Weighed On By Its Debt Load?
Jan 16
Avadel May Continue To Outperform With Positive Launch Momentum
Jan 11Is Avadel Pharmaceuticals (NASDAQ:AVDL) Using Debt Sensibly?
Sep 22Are Investors Undervaluing Avadel Pharmaceuticals plc (NASDAQ:AVDL) By 49%?
Aug 01Is There An Opportunity With Avadel Pharmaceuticals plc's (NASDAQ:AVDL) 45% Undervaluation?
May 03Avadel Pharmaceuticals filed for 500M mixed shelf offering
Aug 31Avadel Pharmaceuticals Q2 2022 Earnings Preview
Aug 08Avadel Pharmaceuticals (NASDAQ:AVDL) Is Carrying A Fair Bit Of Debt
Jul 07Avadel rises 18% as it expects tentative approval for sleep disorder drug; expects final approval by June 2023
Jun 29Avadel: Further Delay, But Some Light At The End Of The Tunnel
Jun 16Avadel Pharmaceuticals Plc: Initiating Buy, Bye Bye To Sleepiness
Mar 21Health Check: How Prudently Does Avadel Pharmaceuticals (NASDAQ:AVDL) Use Debt?
Mar 15Health Check: How Prudently Does Avadel Pharmaceuticals (NASDAQ:AVDL) Use Debt?
Nov 19Avadel Pharmaceuticals: I Am Holding
Nov 01Avadel Pharmaceuticals, The Jazz-Killer
Aug 05Is Avadel Pharmaceuticals (NASDAQ:AVDL) Using Debt In A Risky Way?
Jul 23Avadel presents new clinical data from Phase 3 REST-ON trial of FT218 in narcolepsy
Jun 09Avadel Pharmaceuticals EPS beats by $0.09
May 10Need To Know: The Consensus Just Cut Its Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates For 2021
Mar 11Is Avadel Pharmaceuticals plc (NASDAQ:AVDL) Popular Amongst Institutions?
Feb 05
Avadel Pharmaceuticals' (NASDAQ:AVDL) Stock Price Has Reduced 35% In The Past Three Years
Jan 10Avadel files US application for its lead drug
Dec 16Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$106m |
| Mar 31 2024 | n/a | n/a | -US$157m |
| Dec 31 2023 | US$985k | US$600k | -US$160m |
| Sep 30 2023 | n/a | n/a | -US$159m |
| Jun 30 2023 | n/a | n/a | -US$143m |
| Mar 31 2023 | n/a | n/a | -US$142m |
| Dec 31 2022 | US$754k | US$561k | -US$137m |
| Sep 30 2022 | n/a | n/a | -US$132m |
| Jun 30 2022 | n/a | n/a | -US$134m |
| Mar 31 2022 | n/a | n/a | -US$90m |
| Dec 31 2021 | US$3m | US$545k | -US$77m |
| Sep 30 2021 | n/a | n/a | -US$66m |
| Jun 30 2021 | n/a | n/a | -US$56m |
| Mar 31 2021 | n/a | n/a | -US$6m |
| Dec 31 2020 | US$3m | US$520k | US$7m |
| Sep 30 2020 | n/a | n/a | US$16m |
| Jun 30 2020 | n/a | n/a | US$18m |
| Mar 31 2020 | n/a | n/a | -US$21m |
| Dec 31 2019 | US$1m | US$472k | -US$33m |
| Sep 30 2019 | n/a | n/a | -US$94m |
| Jun 30 2019 | n/a | n/a | -US$101m |
| Mar 31 2019 | n/a | n/a | -US$96m |
| Dec 31 2018 | US$685k | US$417k | -US$95m |
| Sep 30 2018 | n/a | n/a | -US$40m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | n/a | n/a | US$30m |
| Dec 31 2017 | US$1m | US$375k | US$68m |
Compensazione vs Mercato: La retribuzione totale di Greg ($USD 985.20K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 5.62M ).
Compensazione vs guadagni: La retribuzione di Greg è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Greg Divis (57 yo)
5.6yrs
Mandato
US$985,200
Compensazione
Mr. Gregory J. Divis Jr., also known as Greg, has been Director of Avadel Pharmaceuticals plc since June 3, 2019 and has been its Chief Executive Officer since January 2019. Mr. Divis served as an Interim...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 5.6yrs | US$985.20k | Nessun dato | |
| Senior VP | 4.7yrs | US$663.14k | 0.084% $ 1.3m | |
| Chief Commercial Officer | 3.5yrs | US$770.95k | 0% $ 0 | |
| General Counsel & Company Secretary | 3.9yrs | Nessun dato | 0.0091% $ 145.2k | |
| VP of Corporate and Business Development | 9.1yrs | Nessun dato | 0.17% $ 2.6m | |
| Vice President of Sales | 8yrs | Nessun dato | Nessun dato | |
| Vice President of People & Culture | 3.3yrs | Nessun dato | Nessun dato | |
| Consultant | 5.3yrs | US$982.54k | Nessun dato | |
| Senior Vice President of Technical Operations | 4.7yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Medical & Clinical Affairs | no data | Nessun dato | Nessun dato |
4.7yrs
Durata media
56yo
Età media
Gestione esperta: Il team dirigenziale di AVDL è considerato esperto (durata media dell'incarico 4.7 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | US$985.20k | Nessun dato | |
| Member of Scientific Advisory Board | 19.6yrs | Nessun dato | Nessun dato | |
| Independent Director | 4.7yrs | US$449.84k | 0.070% $ 1.1m | |
| Independent Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | 7.2yrs | US$459.84k | 0.086% $ 1.4m | |
| Member of Scientific Advisory Board | 19.6yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 5.7yrs | US$452.34k | 0.17% $ 2.8m | |
| Chairman of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Non-Executive Chairman of the Board | 6.1yrs | US$482.34k | 0.13% $ 2.1m | |
| Independent Director | 6.1yrs | US$452.34k | 0.054% $ 864.6k |
6.1yrs
Durata media
62yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di AVDL sono considerati esperti (durata media dell'incarico 6.1 anni).